{'url': 'https://www.cancer.gov/news-events/cancer-currents-blog/2022/fda-brentuximab-children-hodgkin-lymphoma', 'method': 'GET', 'status': 200, 'response_url': 'https://www.cancer.gov/news-events/cancer-currents-blog/2022/fda-brentuximab-children-hodgkin-lymphoma', 'timestamp': 1711314640.2956252}